Trypanosoma brucei gambiense-iELISA: A Promising New Test for the Post-Elimination Monitoring of Human African Trypanosomiasis.
Geerts M, Van Reet N, Leyten S, Berghmans R, Rock KS, Coetzer THT, Eyssen LE, Büscher P.
Clin Infect Dis. 2021 Nov 2;73(9):e2477-e2483. doi: 10.1093/cid/ciaa1264.
PMID:32856049
Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S, Efferth T.
Int J Mol Med. 2008 Oct;22(4):411-9.
PMID:18813846
Identification of Trypanosoma brucei gambiense in naturally infected dogs in Nigeria.
Umeakuana PU, Gibson W, Ezeokonkwo RC, Anene BM.
Parasit Vectors. 2019 Aug 27;12(1):420. doi: 10.1186/s13071-019-3680-8.
PMID:31455430
Target product profile: Trypanosoma brucei gambiense test for low-prevalence settings.
Priotto G, Franco JR, Lejon V, Büscher P, Matovu E, Ndung'u J, Biéler S, Mumba D, Van Reet N, Verlé P, Jamonneau V, Simarro PP, Ebeja AK, Sankara D, Dagne DA.
Bull World Health Organ. 2023 Aug 1;101(8):541-545. doi: 10.2471/BLT.23.290176. Epub 2023 Jun 26.
PMID:37529025
The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human african trypanosomiasis.
Jackson AP, Sanders M, Berry A, McQuillan J, Aslett MA, Quail MA, Chukualim B, Capewell P, MacLeod A, Melville SE, Gibson W, Barry JD, Berriman M, Hertz-Fowler C.